Sort
25,944 grants matching “neurodegeneration”
Evolving New Glycosaminoglycan Mimetics
$384,183Linda C Hsieh-Wilson · California Institute Of Technology · R01 · FY2021 · GM
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
$384,133Udai B Pandey · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · NS
Signal Transduction by alphavbeta8 Integrin
$384,120Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS
Biogenesis of macromolecular machines for post-transcriptional regulation of translation
$384,098Homa Ghalei · Emory University · R35 · FY2024 · GM
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome
$384,088Kelly D. Sullivan · University Of Colorado Denver · R01 · FY2020 · AI
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome
$384,088Kelly D. Sullivan · University Of Colorado Denver · R01 · FY2021 · AI
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome
$384,088Kelly D. Sullivan · University Of Colorado Denver · R01 · FY2019 · AI
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome
$384,088Kelly D. Sullivan · University Of Colorado Denver · R01 · FY2022 · AI
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome
$384,088Kelly D. Sullivan · University Of Colorado Denver · R01 · FY2023 · AI
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis
$384,050Arthi Kanthasamy · University Of Georgia · R01 · FY2022 · NS
Effects of modified erythropoietin on cognition and neuropathology
$384,046Michael P McDonald · University Of Tennessee Health Sci Ctr · R01 · FY2017 · NS
Metabolic Vulnerability of Synapses in Neurodegenerative Disease
$383,997Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
$383,920Udai B Pandey · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · NS
Animal Models for Studying Human Frontotemporal Dementia
$383,906Fen-Biao Gao · J. David Gladstone Institutes · R01 · FY2009 · NS
Animal Models for Studying Human Frontotemporal Dementia
$383,906Fen-Biao Gao · J. David Gladstone Institutes · R01 · FY2008 · NS
Clinically Relevant Biomarkers for Niemann-Pick Type C
$383,824Stephanie M Cologna · University Of Illinois At Chicago · U01 · FY2023 · FD
Development of an ophthalmic diagnostic probe for neurodegenerative disorders
$383,810Stella Sarraf · Amydis Diagnostics, Inc. · R43 · FY2015 · AG
Enhance Neuroprotection through post-transcriptional regulations
$383,750Rong Grace Zhai · University Of Miami School Of Medicine · R56 · FY2017 · NS
Typical and Pathological Cellular Development of the Human Amygdala
$383,750Cynthia Schumann · University Of California At Davis · R01 · FY2011 · MH
Project 4: Pesticides and Genes In PD: Studies In Humans
$383,750Beate R Ritz · University Of California Los Angeles · P01 · FY2009 · ES
Probing Neurodegeneration with Drosophila
$383,750Juan Botas · Baylor College Of Medicine · R56 · FY2008 · NS
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
$383,750Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2023 · DA
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
$383,750Kathleen E. Rodgers · University Of Arizona · U01 · FY2022 · AG
Targeting STAU1 for TDP-43 proteinopathies
$383,748Daniel R Scoles · University Of Utah · R61 · FY2022 · NS
Mechanisms of mTORC1 signaling to protein degradation pathways
$383,746Do-Hyung Kim · University Of Minnesota · R35 · FY2021 · GM